ACTL6A and non-small cell lung carcinoma: Previous studies showed that overexpression of ACTL6A maintains an aggressive mesothelioma cancer cell phenotype by reducing p21 expression [16] and promotes the proliferation in NSCLC by regulating Hippo/YAP pathway [17].